Verona Pharma PLC Director's Dealing (9407E)
February 16 2015 - 2:01AM
UK Regulatory
TIDMVRP
RNS Number : 9407E
Verona Pharma PLC
16 February 2015
Verona Pharma plc
("Verona Pharma" or the "Company")
Director's Dealing
16 February 2015, Cardiff- Verona Pharma plc (AIM: VRP) received
notification on 13 February 2015 that on that date Dr. Jan-Anders
Karlsson, CEO of the Company, purchased 1,025,909 ordinary shares
of 0.1p each in the Company ("Ordinary Shares") at a price of 2
pence per share.
Following the acquisition, Dr. Karlsson will have an interest in
the Company of 2,735,000 Ordinary Shares, representing 0.27% of the
Company's issued share capital.
-Ends-
For further information please contact:
Verona Pharma plc Tel: +44 (0) 20 3283
4200
Jan-Anders Karlsson, CEO
N+1 Singer Tel: +44 (0)20 7496 3000
Aubrey Powell / Jen Boorer
FTI Consulting Tel: +44 (0)20 3727 1000
Julia Phillips / Simon
Conway
Notes to Editors
About Verona Pharma plc
Verona Pharma plc is a UK-based clinical stage biopharmaceutical
company focused on the development of innovative prescription
medicines to treat respiratory diseases with significant unmet
medical needs, such as COPD, asthma and cystic fibrosis. Verona
Pharma's lead drug, RPL554, is a first-in-class drug currently in
Phase II trials as a nebulised treatment for acute exacerbations of
COPD in the hospital setting. The drug is a dual phosphodiesterase
(PDE) 3/4 inhibitor and therefore has both bronchodilator and
anti-inflammatory effects, which are essential to the improvement
of patients with COPD and asthma. Verona Pharma is also building a
broader franchise around RPL554 to maximise its value, both to
patients and to investors. This includes the very significant
markets for COPD and asthma maintenance therapy. The Company is
also exploring the potential of the drug in different diseases,
such as cystic fibrosis, where it is in pre-clinical testing.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSDELFFELFXBBV
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024